CClinicalTrials.gg
Status unknownNCT01717092Updated Feb 27, 2014

Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China

An observational study in To Assess the Long-term Risk for Adverse Events After PE., sponsored by Air Force Military Medical University, China. Status unknown at 2 sites in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-02-27.

Sponsored by Air Force Military Medical University, China · Observational

The sponsor has not verified this record recently (last verified Feb 2014), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Chronic thromboembolic pulmonary hypertension (CTPH) is associated with considerable morbidity and mortality. Its incidence after pulmonary embolism and associated risk factors are not well documented in Chinese population. We conducted a prospective, long-term, follow-up study to assess the incidence of symptomatic CTPH in consecutive patients with an acute episode of pulmonary embolism but without prior venous thromboembolism. Patients with unexplained persistent dyspnea during follow-up underwent transthoracic echocardiography and, if supportive findings were present, ventilation-perfusion lung scanning and pulmonary angiography. CTPH was considered to be present if systolic and mean pulmonary-artery pressures exceeded 40 mm Hg and 25 mm Hg, respectively; pulmonary-capillary wedge pressure was normal; and there was angiographic evidence of disease.

02

Conditions studied

  • To Assess the Long-term Risk for Adverse Events After PE.
03

In context

Lead sponsor

Air Force Military Medical University, China is the lead sponsor of 172 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Consecutive patients with an acute episode of pulmonary embolism but without prior venous thromboembolism.

Inclusion criteria

  • Patients with an episode of acute symptomatic pulmonary embolism without prior pulmonary embolism or venous thrombosis

Exclusion criteria

Exclusion Criteria:

  • Have other diseases (e.g., systemic sclerosis or severe emphysema) that could have caused nonthromboembolic pulmonary hypertension,
  • Have preexisting exertional dyspnea,
  • Geographically inaccessible for follow-up,
  • Decline to participate in the study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)

Groups and cohorts

  • Consecutive patients with acute PE
06

What researchers measure

Primary outcomes

  1. The cumulative incidence of symptomatic CTEPH

    Time frame: 2 years

Secondary outcomes

  1. Risk factors for Recurrent VTE and CTEPH

    Time frame: 2 years

07

Study locations

2 of 2 sites recruiting
  • Tangdu hospital
    Xi'an, Shaanxi 710032, China
    Recruiting
  • Xijing hospital
    Xi'an, Shaanxi 710032, China
    • Yongping Yu, MD · Contact · yuyongping_6100@163.com · +86-29-84771132
    • Yongping Yu, MD · Sub investigator
    • Xinpeng Han, MD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01717092
Lead sponsor
Air Force Military Medical University, China
Responsible party
Shengqing Li (MD, PhD, Associate Chief Physician, Associate Professor, Air Force Military Medical University, China) — Principal investigator
First posted
Oct 30, 2012
Start date
Oct 2012
Primary completion
Oct 2015 (estimated)
Completion
Oct 2015 (estimated)
Last update
Feb 27, 2014

Study contacts

Shengqing Li, MD, PhD
Contact
shengqingli@gmail.com
+86-29-84771132

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion